But before that we’ll cover a talk by Flagship Pioneering CEO Noubar Afeyan and Novartis President Victor Bulto; a panel featuring top voices at Teva, Eli Lilly, and Astellas; an AI deep dive ...

On that note, time to hustle. Best of luck, and do keep in touch. … When Eli Lilly last year started offering lower-priced vials of its blockbuster obesity drug Zepbound, which were previously ...

The drug was first approved in the 1990s and is currently marketed by Eli Lilly under the brand name Zyprexa. Teva, which launched a Dr. Reddy’s-partnered generic to Zyprexa in 2011, spotted a ...

A new study from the University of Iowa finds that many drug prices actually drop after pharmaceutical company mergers, ...

Eli Lilly partners with VC to launch 700 billion won biotech ecosystem fund Eli Lilly collaborates with a16z to create a vast ...

Pharmaceutical Innovations, Collaborative Research Initiatives, and Increased Awareness Driving Clostridium Difficile Infection Treatment Market GrowthRockville, MD, Jan. 23, 2025 (GLOBE NEWSWIRE) -- ...

Teva launched an authorized generic for Victoza ... Meanwhile, Novo’s chief rival in the metabolic medicine space, Eli Lilly, adopted a similar tack this week when it filed a motion to intervene ...

New York, New York-- (Newsfile Corp. - January 22, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...

“The point is that, according to the researchers’ argument, deprivation lies on a path of cause and effect going from having ADHD to having a lower life expectancy, and adjusting for deprivation could ...

New York, New York-- (Newsfile Corp. - January 20, 2025) - Leading securities law firm Bleichmar Fonti & Auld LLP announces that a lawsuit has been filed against BioAge Labs, Inc. (NASDAQ: BIOA) and ...

This allowed Regeneron and Teva to continue with trials on fasinumab, and Pfizer and Eli Lilly to resume trials into tanezumab. The latest results from Regeneron and Teva are from a sub-study in a ...

Lupin Ltd., a global pharmaceutical company, announced on December 30, the acquisition of the Huminsulin range of products in India from Eli Lilly and ... citing that, Teva’s petition for ...